1. 106316803 一种SGLT-2抑制剂中间体的合成方法
CN
11.01.2017
C07C 43/225 Loading...
C07C 43/225
Loading...
201510343485.9
重庆博腾制药科技股份有限公司
林文清
C07C 43/225
Loading...
本发明公开了一种SGLT-2抑制剂中间体的制备方法。该方法主要是利用硼氢化钠(NaBH4)和三甲基氯硅烷(TMSCl)复合还原剂，将羰基还原为亚甲基。该路线具有副反应少、对环境相对友好、价格便宜、原料易得和利于规模化生产等特点。
2. 106256819 一种(4S)‑N‑Boc‑4‑甲氧基甲基‑L‑脯氨酸胺盐的合成方法
CN
28.12.2016
C07D 207/16 Loading...
C07D 207/16
Loading...
201610383150.4
重庆博腾制药科技股份有限公司
林文清
C07D 207/16
Loading...
本发明公开了一种(4S)‑N‑Boc‑4‑甲氧基甲基‑L‑脯氨酸胺盐(TM)的合成方法，包括以下步骤：a.将(2S)‑N‑Boc‑4‑甲氧基甲叉吡咯烷‑2‑羧酸与NR1R2R3胺化物反应，制得(2S)‑N‑Boc‑4‑甲氧基甲叉吡咯烷‑2‑羧酸胺盐；b.(2S)‑N‑Boc‑4‑甲氧基甲叉吡咯烷‑2‑羧酸胺盐经钯碳氢化还原反应制得(4S)‑N‑Boc‑4‑甲氧基甲基‑L‑脯氨酸胺盐；其中，所述R1、R2、R3独立选自氢和烃基化合物;通过成盐体系，使得氧化体系效率更高，产品更易于纯化分离，所获得的产品纯度高，稳定性好，原料成本和生产成本相对较低，且不存在安全隐患问题，即经济又环保。
3. WO/2016/202232 SYNTHESIS METHOD FOR (4S)-N-BOC-4-METHOXY METHYL-L-PROLINE AMINE SALT
WO
22.12.2016
C07D 207/16 Loading...
C07D 207/16
Loading...
PCT/CN2016/085661
PORTON FINE CHEMICALS LTD
LIN, Wenqing
C07D 207/16
Loading...
Disclosed is a synthesis method for (4S)-N-Boc-4-methoxy methyl-L-proline amine salt (TM), comprising the following steps: a. React (2S)-N-Boc-4-methoxy methylene pyrrolidine-2-carboxylic acid with NR1R2R3 amine compound to obtain (2S)-N-Boc-4-methoxy methylene pyrrolidine-2-carboxylic acid amine salt; and b. Obtain (4S)-N-Boc-4-methoxy methyl-L-proline amine salt from (4S)-N-Boc-4-methoxy methyl-L-proline amine salt by palladium carbon hydrogen reduction reaction, R1, R2, and R3 being independently selected from hydrogen and hydroxyl compounds. By using a salt-forming system, the oxidation system is more efficient and the product is easier to separate and purify, thereby the obtained product has a high purity and a good stability. A raw material cost and a production cost are relatively low, and there is no potential safety hazard, which is economic and environment-friendly.
4. 104496795 一种DGAT-1抑制剂中间体的制备方法
CN
14.09.2016
C07C 57/62 Loading...
C07C 57/62
Loading...
102014000772552
重庆博腾制药科技股份有限公司
王雷明
C07C 57/62
Loading...
本发明公开了一种DGAT‑1抑制剂中间体的制备方法，其步骤包括将反‑4‑(4‑卤苯基)环己基甲酰氯和重氮甲烷反应，生成反‑4‑(4‑卤苯基)环己基重氮酮，再将反‑4‑(4‑卤苯基)环己基重氮酮沃尔夫重排，生成反‑4‑(4‑卤苯基)环己基乙酸。本发明减少了反应步数，降低了原料成本。
5. 105801518 一种(S)-1-Boc-3-羟基哌啶的合成方法
CN
27.07.2016
C07D 295/205 Loading...
C07D 295/205
Loading...
201410833709.X
重庆博腾制药科技股份有限公司
彭磊
C07D 295/205
Loading...
本发明公开了一种(S)-1-Boc-3-羟基哌啶的合成方法，以(R)-甘油醛缩丙酮为原料，通过witting反应上乙腈基、钯炭还原双键、脱保护、选择性上对甲苯磺酰基、雷尼镍加氢还原腈基同时关环，再进行哌啶环氮Boc保护，从而获得(S)-1-Boc-3-羟基哌啶，该方法直接以廉价的手性原料作为起始物料，获得手性产品，避免了拆分工艺的巨大物料消耗和收率损失。
6. 105801462 一种(4S)-N-Boc-4--甲氧基甲基-L-脯氨酸的合成方法
CN
27.07.2016
C07D 207/16 Loading...
C07D 207/16
Loading...
201410836352.0
重庆博腾制药科技股份有限公司
林文清
C07D 207/16
Loading...
本发明公开了一种(4S)-N-Boc-4--甲氧基甲基-L-脯氨酸的合成方法，包括以L-羟基脯氨酸为起始原料，经过Boc保护得到N-Boc-L-羟基脯氨酸的步骤；将N-Boc-L-羟基脯氨酸溶于溶剂中与TEMPO(四甲基哌啶氮氧化物)氧化反应得到(2S)-N-Boc-4-氧代吡咯烷-2-羧酸的步骤；将(2S)-N-Boc-4-氧代吡咯烷-2-羧酸和甲氧基甲基三苯基氯化鏻溶于溶剂中进行wittig反应制得(2S)-N-Boc-4-甲氧基甲叉吡咯烷-2-羧酸的步骤；将(2S)-N-Boc-4-甲氧基甲叉吡咯烷-2-羧酸和叔丁胺溶于水中经氢化反应制得(4S)-N-Boc-4--甲氧基甲基-L-脯氨酸；该反应缩短了反应步骤；避免了剧毒氰化物的使用，增加了安全性和降低了环保压力；搞高了原子经济性，减少了废物的排放；原料成本大幅下降。
7. 104530000 一种醛固酮合酶调节剂中间体的制备方法
CN
20.07.2016
C07D 401/04 Loading...
C07D 401/04
Loading...
102014000765232
重庆博腾制药科技股份有限公司
杨细文
C07D 401/04
Loading...
本发明公开了一种醛固酮合酶调节剂中间体的制备方法，其步骤为将Boc保护下的反应底物在氯化氢和乙醇中反应上缩醛保护，不分离直接加热脱除Boc保护，然后进行N?甲基化反应得到N?甲基化产物，不分离直接脱缩醛保护，得到目标产物。本发明的路线反应转化率高，产物纯度高，可以有效保证产品质量，并且能实现车间生产。
8. 103804208 Method for preparing drug intermediate for hepatitis c
CN
21.05.2014
C07C 227/34 Loading...
C07C 227/34
Loading...
201210454022.6
重庆博腾制药科技股份有限公司
王岭
C07C 227/34
Loading...
The invention relates to a method for preparing a drug intermediate for hepatitis c. More specifically, only dihydroxysuccinic acid (D-DTTA) is adopted as a resolving agent to split under a specific condition, and the split crude product is crystallized again under the specific condition, so as to obtain the product with high purity.
9. 103664564 Preparation method of analgesic intermediate compound
CN
26.03.2014
C07C 49/84 Loading...
C07C 49/84
Loading...
201210325871.1
重庆博腾制药科技股份有限公司
郑星
C07C 49/84
Loading...
The invention discloses a preparation method of meta-methoxypropiophenone shown in Formula I. The specific synthetic route is as shown in the specification.
10. 103570601 一种光学活性药物中间体的制备方法
CN
12.02.2014
C07D 207/14 Loading...
C07D 207/14
Loading...
201210253609.0
重庆博腾制药科技股份有限公司
徐平洲
C07D 207/14
Loading...
本发明涉及一种以具有光学活性的化合物为起始物料制备一种光学活性的式I所示化合物或其盐酸盐的制备方法。本方法所用的原料廉价、易得，不用使用拆分，整个工艺操作简便，成本低且对环境污染少，适合工业化生产。其中，n为1或2或3。
11. 103387509 Preparation method of HCV protease inhibitor intermediate
CN
13.11.2013
C07C 235/82 Loading...
C07C 235/82
Loading...
201210146447.0
重庆博腾制药科技股份有限公司
林文清
C07C 235/82
Loading...
The invention provides a preparation method of an intermediate bicyclic lactone amide (I) of HCV protease inhibitor TMC435. According to the invention, a cinchonidine salt (IV) is adopted as a raw material, and forms mixed anhydride (III) with a chloroformate compound; and the mixed anhydride is subjected to condensation with N-methyl-cyclohexene amine (NMHA) (II), such that the target product bicyclic lactone amide compound (I) is obtained.
12. 102358725 一种异恶唑类化合物的中间体的制备方法
CN
22.02.2012
C07C 271/22 Loading...
C07C 271/22
Loading...
201110346676.2
重庆博腾制药科技股份有限公司
朱坡
C07C 271/22
Loading...
本发明涉及一种可用于制备异噁唑类化合物的重要中间体2-氨基-N-2，2，2-三氟乙基乙酰胺(IV)及其盐的制备方法，该方法以N-叔丁氧羰基甘氨酸为原料，经过几步常规反应得到产品。
13. WO/2012/016479 METHOD FOR PREPARING ROSUVASTATIN CALCIUM INTERMEDIATE
WO
09.02.2012
C07D 239/42 Loading...
C07D 239/42
Loading...
PCT/CN2011/075757
PORTON FINE CHEMICALS LTD.
LIN, Wenqing
C07D 239/42
Loading...
Disclosed is a method for preparing rosuvastatin calcium intermediate of formula I, which comprises hydrolyzing an ester compound of formula II (R is C1～C5 alkyl) in the presence of a metal compound to obtain a carboxylic acid compound of formula III, and then reducing the carboxylic acid compound under a specific reduction condition to obtain rosuvastatin calcium intermediate of formula I.
14. WO/2011/124050 ROSUVASTATIN CALCIUM INTERMEDIATE AND PREPARATION METHOD THEREOF
WO
13.10.2011
C07F 9/535 Loading...
C07F 9/535
Loading...
PCT/CN2010/075519
PORTON FINE CHEMICALS LTD.
LIN, Wenqing
C07F 9/535
Loading...
A rosuvastatin calcium intermediate as shown by Formula I is prepared as follow: a) subjecting chloroethylene, magnesium and R-epoxy chloropropane to Grignard reaction, b) adding sodium cyanide for nucleophilic substitution reaction, c) adding alcohol for alcoholysis reaction, d) adding alkaline solvent for hydroxyl protection, e) subjecting the mixture to oxidation reaction, f) adding triphenyl phosphorus and subjecting to Wittig reaction in the presence of alkali to obtain the compound of formula I. The method has moderate reaction conditions, is convenient and stable and can be applied to industrial production.
15. 102212082 Rosuvastatin calcium intermediate and preparation method thereof
CN
12.10.2011
C07F 9/535 Loading...
C07F 9/535
Loading...
201010179187.8
Chongqing Porton Pharmaceutical Technology Co.,Ltd.
Lin Wenqing
C07F 9/535
Loading...
The invention discloses a rosuvastatin calcium intermediate and a preparation method thereof and belongs to the field of chemical medicament synthesis. The preparation method of the rosuvastatin calcium intermediate which is a compound shown in a general formula I (R is alkyl, and Y is hydroxyl protective group) comprises the following steps: based on R-epichlorohydrin serving as a raw material, carrying out Grignard reaction, cymag nucleophilic substitution reaction, alcoholysis reaction, hydroxyl protection, addition reaction, oxidation reaction and Wittig reaction, so as to prepare the compound as shown in the general formula I. According to the invention, the method has a simple condition and no high-temperature high-pressure reaction, and the used raw material, a catalyst and an oxidant are easily obtainable; and the process is stable, the product yield is higher, a large amount of three wastes are not generated, and environmental pollution is small, thus, the method is suitable for industrial production on a large scale.
16. 101955463 Method for preparing rosuvastatin calcium intermediate
CN
26.01.2011
C07D 239/42 Loading...
C07D 239/42
Loading...
201010244963.8
Chongqing Boteng Pharmaceutical Co., Ltd.
Lin Wenqing
C07D 239/42
Loading...
The invention discloses a method for preparing a rosuvastatin calcium intermediate (i.e. a compound shown in a formula I), which comprises the following steps: hydrolyzing an ester compound shown in a formula II (R refers to C1 to C5 alkyls) into a carboxylic acid compound shown in a formula III in the presence of a metallic compound; and then reducing the carboxylic acid compound into the rosuvastatin calcium intermediate shown in the formula I under the condition of a special reduction system.
17. 101935263 Method for preparing amino acid derivative
CN
05.01.2011
C07B 43/04 Loading...
C07B 43/04
Loading...
201010224234.6
Chongqing Boteng Pharmaceutical Technology Co., Ltd.
Lin Wenqing
C07B 43/04
Loading...
The invention provides a method for preparing an amino acid derivative, i.e. a compound of the general formula I. The derivative is an important intermediate of medical products such as antiviral drugs, and the like. The method has the advantages that a simple and easily obtained compound is used as a raw material, the yield is stable and higher, and the process is safe and easy to industrialize, thus the method provides an important condition for reducing the cost of antiviral drugs.
18. 101935304 Rosuvastatin glycine tert-butyl ester salt and preparation method thereof
CN
05.01.2011
C07D 239/42 Loading...
C07D 239/42
Loading...
201010205807.0
Chongqing Boteng Pharmaceutical Technology Co., Ltd.
Liu Nian
C07D 239/42
Loading...
The invention relates to an intermediate of rosuvastatin calcium, namely rosuvastatin glycine tert-butyl ester salt shown in formula I, and a preparation method thereof.
19. 101817820 Method for synthesizing moxifloxacin hydrochloride
CN
01.09.2010
C07D 471/04 Loading...
C07D 471/04
Loading...
200910104481.X
Chongqing Boteng Fine Chemical Co., Ltd.
Shen Hao
C07D 471/04
Loading...
The invention relates to a method for synthesizing a broad-spectrum efficient moxifloxacin hydrochloride, which is a quinolone antimicrobial medicament and has a formula below.
20. 101735272 Method for preparing rosuvastatin calcium midbody
CN
16.06.2010
C07F 9/535 Loading...
C07F 9/535
Loading...
200910191881.9
Chongqing Boteng Fine Chemical Co., Ltd.
Lin Wenqing
C07F 9/535
Loading...
The invention discloses a method for preparing a rosuvastatin calcium midbody, namely a compound (R is C1-C10 alkyl, and Y is a hydroxyl protecting group) shown as the general formula I. Chloroethylene and R-epoxy chloropropane as initial raw materials are carried out seven steps of reaction, such as Grignard reaction, sodium cyanide nucleophilic substitution reaction, alcoholysis reaction, hydroxyl protection, oxidizing reaction, methylchloroformate acylation reaction and Wittig reaction to prepare the compound shown as the general formula I. The method has mild condition, simple and convenient operation, stable process, low cost and easy acquisition of raw materials, high product yield, easy disposal of the three wastes, less environmental pollution, low preparation cost and suitability for industrialized large-scale production.
21. 101279929 Preparation of optically active 3-amino-N-cyclopropyl-2-hydroxyl hexanamide
CN
08.10.2008
C07C 237/06 Loading...
C07C 237/06
Loading...
200710092666.4
Chongqing Boteng Fine Chemistry Industry Co., Ltd.
Lin Wenqing
C07C 237/06
Loading...
The invention provides a method to prepare optically active 3-amido-N- cyclopropyl-2-hydroxyl-hexanamide with structural formula I. The method includes the following steps: N-cyclopropyl-decoyl-2-alkene-acylamide with structural formula II is epoxidized to get compound with structural formula III; then the compound with structural formula III and diazoimido compound react under the existence of acid to open the loops, producing compound with structural formula IV whose azide groups are then deoxidized to produce compound with structural formula V; finally compound with structural formula V is split by optically active acid, thus producing the compound with structural formula I which is an important medical intermediate compound.

